Literature DB >> 1727962

Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine.

C P Howson1, H V Fineberg.   

Abstract

In August 1991, the Institute of Medicine released a report entitled Adverse Effects of Pertussis and Rubella Vaccines, which examined 18 adverse events in relation to diphtheria-tetanus-pertussis (DTP) vaccine and four adverse events in relation to the currently used rubella vaccine strain, RA 27/3. The committee spent 20 months reviewing a wide range of information sources, including case series and individual case reports, both published and unpublished, epidemiologic studies, studies in animals, and other laboratory studies. The committee found that the evidence indicates a causal relation between DTP vaccine and anaphylaxis and between the pertussis component of DTP vaccine and extended periods of inconsolable crying or screaming. The committee also reported that the evidence indicates a causal relation between the rubella vaccine and acute arthritis in adult women. The committee found the available evidence weaker but still consistent with a causal relation between DTP vaccine and two conditions--acute encephalopathy and hypotonic, hyporesponsive episodes--and between rubella vaccine and chronic arthritis in adult women. Estimated incidence rates of these adverse events following vaccination are provided, where possible. The committee found that the evidence does not indicate a causal relation between the DTP vaccine and infantile spasms, hypsarrhythmia, Reye's syndrome, and sudden infant death syndrome. The committee found insufficient evidence to indicate either the presence or absence of a causal relation between DTP vaccine and chronic neurologic damage, aseptic meningitis, erythema multiforme or other rash, Guillain-Barré syndrome, hemolytic anemia, juvenile diabetes, learning disabilities and attention-deficit disorder, peripheral mononeuropathy, or thrombocytopenia, and between rubella vaccine and radiculoneuritis and other neuropathies or thrombocytopenic purpura. The committee's evaluative methods are briefly described and a summary of research needs is provided.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727962

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Genetic basis for variation of vaccine response: our studies with rubella vaccine.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Paediatr Child Health       Date:  2009-12       Impact factor: 2.253

Review 2.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

3.  A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.

Authors:  Lalitendu Mohanty; Sunil Sharma; Beauty Behera; Sachin Panwar; Charu Paliwal; Anit Singh; Anu Gupta; Deepak Chandra Chilkoti
Journal:  Hum Vaccin Immunother       Date:  2017-07-12       Impact factor: 3.452

4.  Revaccination against measles and rubella.

Authors:  F T Cutts
Journal:  BMJ       Date:  1996-03-09

5.  Can immunisation trigger rheumatoid arthritis?

Authors:  D P Symmons; K Chakravarty
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

Review 6.  Acellular pertussis vaccines. Towards an improved safety profile.

Authors:  M E Pichichero
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

7.  Adverse reactions associated with simultaneous administration of multiple vaccines to travelers.

Authors:  C Falvo; H Horowitz
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

8.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.

Authors:  Bas van de Waterbeemd; Gijsbert Zomer; Patricia Kaaijk; Nicole Ruiterkamp; René H Wijffels; Germie P J M van den Dobbelsteen; Leo A van der Pol
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  The multi-systemic nature of diabetes mellitus: Genotype or phenotype?

Authors:  Graham Wilfred Ewing; Syed Hasan Parvez
Journal:  N Am J Med Sci       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.